ADAMTSL5
protein-codingADAMTS like 5, the group of ADAMTS like
Gene summary
Enables heparin binding activity and microfibril binding activity. Predicted to be involved in extracellular matrix organization. Located in microfibril. [provided by Alliance of Genome Resources, Jun 2026]
- THSD6
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ADAMTSL5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_213604.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 98 | 7 | 105 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 101 | 7 | 0 | 108 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_998769.2 | 11 | MANE Select | |
| Ensembl | ENSP00000327608.3 | 11 | MANE Select | |
| RefSeq | NP_001354126.1 | 12 | Standard | |
| Ensembl | ENSP00000378850.2 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Post-translational protein modification
- Metabolism of proteins
- O-glycosylation of TSR domain-containing proteins
- O-linked glycosylation
Molecular Function
- heparin binding
Cellular Component
- microfibril
- extracellular region
- extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000330475
- Coding exons
- 11
- Length
- 8587
- Individuals with no LoFs
- 125606
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 70
- Defined
- 125676
- p
- 0.000279
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.452 | 304 | 283 | 1.08 | 0.0000181 | 2926 |
| Missense (PolyPhen) | 82 | 90.642 | 0.90466 | 954 | ||
| Synonymous | 0.0773 | 120 | 121 | 0.991 | 0.00000772 | 981 |
| Loss of Function | 0.984 | 19 | 24.2 | 0.784 | 0.00000130 | 241 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00057 | 0.00055 | rare |
| Latino/Admixed American | 0.000093 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00022 | 0.00020 | rare |
| East Asian | 0.00084 | 0.00082 | rare |
| Finnish | 0.000095 | 0.000092 | rare |
| European (Non-Finnish) | 0.00026 | 0.00025 | rare |
| South Asian | 0.00034 | 0.00033 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May play a role in modulation of fibrillin microfibrils in the extracellular matrix (ECM).;
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- LoFtool
- 0.894
- RVIS EVS
- 0.44
- RVIS percentile EVS
- 77.85
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.409
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |